Proteostasis Therapeutics Inc.

(PTI) Trade

By |

Profile

Proteostasis Therapeutics Inc is a United States-based company engaged in the biotechnology industry. Its core operations comprise of discovery and development of therapeutics that treat diseases caused by an imbalance in protein biosynthesis process in the body. It has developed the Disease Relevant Translation (DRT) technology platform, a drug screening approach for identifying highly translatable therapeutics. Using this platform, it has identified a new class of small molecules and amplifiers that modulate proteins in the proteostasis network. The products under its development cycle include PTI-428, which is a lead amplifier of CFTR protein. It also focuses on developing PTI-NC-733, PTI-130, Usp14 program and unfolded protein response (UPR) program.

Contact Information

Website: www.proteostasis.com
Email: luke@purecommunicationsinc.com
Main Phone: +1 617 225-0096
Address: 200 Technology Square
Address 2: 4th Floor
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NSD
CEO: Meenu Chhabra
Employees: 50
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Proteostasis Therapeutics Inc is a United States-based company engaged in the biotechnology industry. Its core operations comprise of discovery and development of therapeutics that treat diseases caused by an imbalance in protein biosynthesis process in the body. It has developed the Disease Relevant Translation (DRT) technology platform, a drug screening approach for identifying highly translatable therapeutics. Using this platform, it has identified a new class of small molecules and amplifiers that modulate proteins in the proteostasis network. The products under its development cycle include PTI-428, which is a lead amplifier of CFTR protein. It also focuses on developing PTI-NC-733, PTI-130, Usp14 program and unfolded protein response (UPR) program.

Contact Information

Website: www.proteostasis.com
Email: luke@purecommunicationsinc.com
Main Phone: +1 617 225-0096
Address: 200 Technology Square
Address 2: 4th Floor
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NSD
CEO: Meenu Chhabra
Employees: 50
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 3.17 $ 0.01 (0.32%)
Last Price 3.17 Change $ 0.01 Change % 0.32 Tick N/A
Bid 3.10 Bid Size 1,500.00 Ask 3.40 Ask Size 3,000.00
Open 3.18 High 3.25 Low 3.11 Prev Close 3.16
Last Trade Volume 579,328 52 Wk Hi 10.38 52 Wk Low 1.71
Market Cap 161.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 50,808,422.00 EPS (TTM) -1.75 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 5
Number of Buys 0 5
Number of Sells 0 0
Net Activity 0 4104000
Last 10 Buys Shares
M. James Barrett 1,000
Peter J. Barris 1,000
Franklin M. Berger 1,000
Meenu Chhabra 1,000
Jeffery W. Kelly 1,000
Franklin M. Berger 1,000
Franklin M. Berger 1,000
Peter J. Barris 1,000
Franklin M. Berger 1,000
M. James Barrett 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 25 25 25 25
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 15.25 15.25 15.25 15.25
Standard Deviation 6.85 6.85 6.85 6.85
Date of Most Recent Estimate 05/29/18 05/29/18 03/15/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 1 1 1
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.33 1.33 1.33